Skip to main content

Scientific Program

Scientific Program

 

Registration desk will be open at Nomikos Conference Centre from Sunday, 6.00 p.m.

Welcome reception will be held at Nomikos Conference Centre on Sunday, at 8.00 p.m.

Gala Dinner will be held in Santo Winnery on Tuesdy, at 8.30 p.m. A visit in the Winery will take place at 7.30 p.m.


The duration for all presentations will be 10 min strictly 
(8 min talk, 2 min for discussion)


Monday, 3 July  
Day 1 . First session. Medical Retina. Moderators: I. Pallikaris - J. Christoforidis
9.00 Welcome  
9.10 Dean Cestari CRAO and BRAO. When Does the Retinologist have to Worry about a Stroke?
9.20 Constantin Pournaras OCT angiography features of macular surgical pathologies.
9.30 Thomas Friberg Adaptive Optics imaging in a Retina Practice
9.40 John Christoforidis Intravitreal pharmacokinetic and systemic biodistribution properties of 124I labeled bevacizumab, ranibizumab and aflibercept with PET/CT imaging in a non-human primate model
9.50 Demetrios Vavvas Is there NLRP3 in RPE. Implications for AMD.
10.00 Emmanoul Lazaridis Stereotactic radiotherapy (SRT) in wet AMD: Basic principles and case presentations
10.10 Panagiotis Masaoutis Stereotactic radiotherapy (SRT) in wet AMD: INTREPID Study
10.20 Georgios Kambougeris Stereotactic radiotherapy (SRT) in wet AMD: Real life data
10.30-11.00 Break  
Day 1. Second session. Surgical Retina. Moderators: C. Pournaras - I. Kim
11.00 Jean-Antoine Pournaras Retinal detachment in advanced retinoblastoma
11.10 Elliott Sohn Posteriorly Inserted Vitreous Base (PIVB): Clinical Features and Outcomes 
11.20 Akito Hirakata Vitrectomy for macular retinoschisis associated with glaucomatous optic neuropathy in eye with normal intraocular pressure: a case report
11.30 Hamzah Khalaf Choroidal Hemorrhage and Effusion Drainage From the Pars Plana Using the Choroidal Hematoma Depressor
11.40 Kam Balaggan Pneumatic Displacement for Severe Submacular Haemorrhages in the Setting of a Fast Track Referral Pathway 
11.50 Dean Eliott Multiple Intravitreal Methotrexate Injections for the Prevention of Proliferative Vitreoretinopathy
12.00 Referano Agustiawan Phacoemulsification combined with Pars Plana Vitrectomy and Internal Limiting Membrane Peeling for Diabetic Macular edema
12.10 Yewlin Chee Perforating eye injury with intracranial extension of foreign body
12.20 David Chow 3D Surgery with the NGenuity system - is enhanced stereopsis fact or fiction?
12.30 Rob Mittra

Comparison of techniques for repair of phakic and pseudophakic Rhegmatogenous Retinal Detachment (RRD)

12.40 end of day 1  
     
Tuesday, 4 July  
Day 2. First session. Medical Retina. Moderators: D. Eliott - P. Carvounis
9.00 Thanos Papakostas Genetic Risk Factors for Radiation Vasculopathy
9.10 John Niffenegger Bilateral Diffuse Melanocytic Proliferation Simulating Neovascular Age Related Macular Degeneration in a patient with Stage 4 Papillary Renal-Cell Cancer and MET gene mutation
9.20 Mykola Umanets Bimanual endoresection of uveal melanoma using high-frequency electric welding of biological tissues
9.30 Ivana Kim Long-term follow-up of a 24-month study of ranibizumab for the prevention of radiation vasculopathy
9.40 Evangelos Gragoudas Proton Beam Therapy for Patients with Local Recurrence of Uveal Melanoma
9.50 Umur Kayabasi Diagnosing Chiasmal Tumors by SD- OCT
10.00 George Bontzos Estimation of morphological characteristics in asymmetrical myopic posterior staphyloma using optical coherence tomography
10.10 Miltiadis Tsilimbaris Ηybrid optical and photoacoustic imaging of the ciliary body  
10.20 Iordanis Chatziaggelides TIMELINE: A new educational tool to present the evolution of various retinal diseases through computer generated images (CGI).
10.30-11.00 Break  
Day 2. Second session. Medical/Surgical Retina. Moderators: E. Gragoudas - D. Skondra
11.00 Mrinali Gupta Ocular outcomes of cytomegalovirus (CMV) retinitis treated with adoptive immunotherapy with intravenous CMV-specific cytotoxic T-lymphocytes
11.10 Pauline Merrill Efficacy and Safety Results From the SAKURA Program: Two Phase III Studies of Intravitreal Sirolimus Every Other Month for Non-infectious Uveitis of the Posterior Segment
11.20 Chris Kalogeropoulos  Retinal Vein occlusion: algorithms for the optimization of management in real life
11.30 Petros Carvounis Visual Acuity And Macular Anatomy Following Pars Plana Vitrectomy With Membrane Peel For Idiopathic Epiretinal Membrane In The Elderly 
11.40 Aristomenis Thanos Three port sutureless posterior chamber intraocular lens intrascleral fixation; a novel approach.
11.50 Marc Levy The Implantable Miniature Telescope (IMT) New Developments:  The US and UK Experience
12.00 Spyridon Charisis Vitrectomy, peel, laser and steroids for macular edema
12.10 Mark Humayun Advanced Retinal Implants
12.20 Joseph Rizzo What Are Reasonable Expectations for Visual Prostheses ?
12.30 end of day 2  
     
Wednesday, 5 July  
Day 3. First session. Medical Retina. Moderators: T. Friberg - JA Pournaras
9.00 Georgios  Trichonas 67 y/o male with acute vision loss
9.10 Dimitra Skondra Second Opinion for "CSR"
9.20 Giarmoukakis Thanasis Paracentral Acute Middle Maculopathy (PAMM) in a 15-year old teenager. A case report.
9.30 George Kontadakis Intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study.
9.40 Eleftherios Agorogiannis Treatment outcomes in Caucasians with polypoidal choroidal vasculopathy
9.50 Stella Blazaki Nanotechnology Approaches for Ocular Delivery
10.00-10.30 Break  
Day 3. Second session. Medical Retina. Moderators: M. Tsilimbaris - D. Vavvas
10.30 Sotirios Plainis Reading performance: can we improve inter-individual variability?
10.40 Manos Ktistakis A new method, based on eye movement analysis to evaluate reading performance in patients with AMD
10.50 Aggeliki Gleni Development of standardized IReST texts in Greek for evaluation of reading performance
11.00 Petros Chatzakis Discomfort glare detection made portable
11.10 Larissa Ioannidi The anti-microbial effect of photodynamic therapy using verteporfin and LED in S.aureus
11.20 Closing remarks  
11.30 End of meeting